INS and Hyperglycemia: In ML mice treated with the antagonist GLP1 receptor exendin 9 (Ex9) hyperglycemia during OGTT was much significantly higher than in ML mice (Figure 1D), thus suggesting that GLP1 signaling pathway is involved in glycemic response during OGTT, probably through modulation of insulin secretion.